Search clinical trials for: DA-5210-R 10/500mg

Total 137 results

Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting State

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fed State

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fasting State

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed State

Healthy

Korea, Republic of
NeuroBo Pharmaceuticals Inc.
Dong-A ST Co., Ltd.

Completed

Study of DA-9801 to Treat Diabetic Neuropathy

Diabetic Neuropathy

United States
Dong-A ST Co., Ltd.

Completed

Study of DA-9801 to Treat Diabetic Neuropathic Pain

Diabetic Neuropathies

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Phase III Clinical Trial of DA-5212 in Patients With Functional Dyspepsia

Functional Dyspepsia

Korea, Republic of
Dong-A ST Co., Ltd.

Recruiting

A Clinical Trial to Compare the Safety, Tolerability, and PK Properties of DA-5216 and DA-5216-R and to Evaluate the Food Effect on DA-5216.

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Bioequivalence Study Between "DA-5215 Tab" and "DA-5215-R Tab"

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult Volunteers

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers

Healthy

Korea, Republic of
Yuhan Corporation

Completed

Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male Subjects

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Recruiting

Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients

Hepatitis B

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis

Gastritis Acute | Gastritis Chronic

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1

Type2 Diabetes Mellitus

Korea, Republic of
Rise Therapeutics LLC

Recruiting

R-5280 in Newly Diagnosed Patients With Type 1 Diabetes (R-5280)

Diabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes (Juvenile Onset)

United States
Dana-Farber Cancer Institute
Genentech, Inc.

Recruiting

A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome

Richter Syndrome

United States
Nordic Lymphoma Group
Helsinki University Central Hospital; Aarhus University Hospital

Recruiting

Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis (Bio-CHIC)

Lymphoma, Large B-Cell, Diffuse

Denmark, Norway, Sweden, Finland
Kresge Eye Institute

Suspended

Fluorescein Angiography With a Full-dose Versus a Half-dose of Intravenous Fluorescein

Fluorescein Angiography

United States
HK inno.N Corporation

Completed

Pharmacodynamic Properties of CJ-12420 on Evening Dosing

Healthy

Korea, Republic of
Shandong Provincial Hospital

Recruiting

Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Mantle Cell Lymphoma | Diffuse Large B-cell Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements | B-cell NonHodgkin Lymphoma

China
Henan Cancer Hospital
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Esophageal Carcinoma | Lung Cancer, Nonsmall Cell

China
Elena N.Parovichnikova

Recruiting

R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)

Lymphoma, High-Grade

Russian Federation
Hugo Lovheim

Completed

Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease (VALZ-Pilot)

Alzheimer Disease | Herpes Simplex | Mild Cognitive Impairment

Sweden
Galapagos NV

Completed

Single and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy Subjects

Healthy

Belgium
Avid Radiopharmaceuticals
Pfizer

Completed

Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls

Type 2 Diabetes

United States
Chong Kun Dang Pharmaceutical
Seoul National University Bundang Hospital

Completed

Compare the Pharmacokinetics and Safety of CKD-391

Hyperlipidemias

Korea, Republic of
Dong-A Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803

Infertility | Induction of Ovulation
Imperial College London
AstraZeneca; University of Oxford

Active, not recruiting

A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers (COVAXAER01)

Covid19 | SARS-CoV-2 Infection

United Kingdom
AstraZeneca

Completed

AZD9056 Relative Bioavailability Study

Healthy

United Kingdom
Future University in Egypt

Completed

Bioequivalence Study of Ribavirin in Healthy Adult Subjects Under Fed Condition

Healthy Subjects

Egypt
Stichting Hemato-Oncologie voor Volwassenen Nederland

Active, not recruiting

DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL (HO152)

Lymphoma, B-Cell | Non Hodgkin Lymphoma | High-grade B-cell Lymphoma | MYC Translocation | BCL-2 Translocation

Netherlands, Belgium
Cuda Anesthetics, LLC

Completed

Pilot Study of Bioequivalence of Cudafol(R) and Diprivan(R) Administered as Single Intravenous Doses in Healthy Subjects

Healthy Subjects
Fudan University

Terminated

Dose-adjusted EPOCH-R in MYC Positive DLBCL

Diffuse Large B-cell Lymphoma

China
Shandong Provincial Hospital

Recruiting

Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non Hodgkin Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements

China
Asan Medical Center

Unknown

Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia

Dyspepsia
Changi General Hospital

Completed

RCT: Triple vs Sequential vs Concomitant Therapy H Pylori

Bacterial Infection Due to Helicobacter Pylori (H. Pylori)

Singapore
Dong-A Pharmaceutical Co., Ltd.

Unknown

A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034

Acute Gastritis | Chronic Gastritis

Korea, Republic of
Zodiac Produtos Farmaceuticos S.A.

Unknown

Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis

Candidiasis | Bacterial Vaginosis

Brazil
National Research Center for Hematology, Russia
National Research Center for Hematology

Recruiting

R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis

Diffuse Large B-Cell Lymphoma

Russian Federation
Emory University
National Center for Complementary and Integrative Health (NCCIH); Children's...

Recruiting

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease (R34 pK/PD)

Sickle Cell Disease

United States
Pfizer
Yale University

Terminated

The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.

Diabetes Mellitus

United States
Alexandra Hospital, Athens, Greece
Hellenic Society of Gastroenterology

Completed

Concomitant Versus Hybrid Regimen for H. Pylori Eradication

H.Pylori Infection | H.Pylori Gastrointestinal Disease | H. Pylori Associated Phlegmonous Gastritis

Greece
Pharmacyclics LLC.
Celgene Corporation

Completed

Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B Cell Lymphoma Refractory | Diffuse Large B Cell Lymphoma Relapsed

United States
Mansoura University

Unknown

Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19) (CCOVID-19)

COVID-19

Egypt
London School of Hygiene and Tropical Medicine
University of Sierra Leone; Innovative Medicines Initiative

Completed

Ad26.ZEBOV Booster in Children Previously Vaccinated With Ad26.ZEBOV and MVA-BN-Filo (EBOVAC Booster Study)

Ebola Virus Disease

Sierra Leone

Search clinical trials for: DA-5210-R 10/500mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations